Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas

American Journal of Pathology

Volumn 161, Issue 3, 2002, Pages 929-938

  Baker, Cheryl H ^a   Kedar, Daniel ^a   McCarty, Marya F ^a   Tsan, Rachel ^a   Weber, Kristen L ^a   Bucana, Corazon D ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 (4 HYDROXYPHENYL) 4 (ALPHA METHYLBENZYLAMINO) 7H PYRROLO[2,3 D]PYRIMIDINE; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; GEMCITABINE; PACLITAXEL; PROTEIN TYROSINE KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CANCER; MALE; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TARGET CELL;

EID: 0036733591     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64253-8     Document Type: Article

References (41)

1. Preclinical profile of PKI 166-a novel and potent EGF-R tyrosine kinase inhibitor for clinical development
2. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma
3. Optimization for the blockade of the epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma
4. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
5. Conditioned switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
6. Regulation of distinct steps of angiogenesis by different angiogenic molecules
7. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas
8. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells
9. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-α: Balance between growth and death signals
10. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
11. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression
12. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation
13. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology
14. Transforming growth factor-α: A more potent angiogenic mediator than epidermal growth factor
15. Expression of growth factors and growth factor receptors in capillary hemangioblastoma
16. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factors by phosphorothioate oligodeoxynucleotides
17. Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy
18. Chemosensitization of murine fibrosarcoma cells to drugs affected by the multidrug resistance phenotype by the antidepressant trazodone: An experimental model for the reversal of intrinsic drug resistance
19. The effects of a constitutive expression of transforming growth factor-α on the growth of MCF-7 human breast cancer cells in vitro and in vivo
20. In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice
21. Antiepidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice
22. In vivo selection of human renal cell carcinoma cells with high metastatic potential in nude mice
23. Regulation of renal cell bone metastasis by EGF-R signaling: A novel therapeutic target
24. The distribution of secondary growths in the cancer of the breast
25. Modulation of the organ microenvironment for the treatment of cancer metastasis
26. Cytotoxic activity of epidermal growth factor Genistein against breast cancer cells
27. In vivo toxicity, pharmacokinetics, and anticancer activity for Genistein linked to recombinant human epidermal growth factor
28. Identification of EGF as an angiogenic factor present in conditioned medium from human salivary gland adenocarcinoma cell clones with varying degrees of metastatic potential
29. Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells
30. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells
31. Epidermal growth factor promotes chick embryonic angiogenesis
32. The Egr-1 gene is induced by epidermal growth factor in ECV304 cells and primary endothelial cells
33. Establishing a link between oncogenes and tumor angiogenesis
34. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells
35. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSosl
36. Mutant ras oncogene upregulated VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
37. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells
38. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases downregulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors
39. Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase
40. EGF receptor
41. Production of transforming growth factor-α in human pancreatic cancer cells: Evidence for a superagonist autocrine cycle